Zepp Health/$ZEPP
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Zepp Health
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands.
Ticker
$ZEPP
Sector
Digital Hardware
Primary listing
NYSE
Employees
765
Headquarters
Website
Zepp Health Metrics
BasicAdvanced
$575M
-
-$4.84
1.12
-
Price and volume
Market cap
$575M
Beta
1.12
52-week high
$43.93
52-week low
$2.13
Average daily volume
768K
Financial strength
Current ratio
1.097
Quick ratio
0.528
Long term debt to equity
31.939
Total debt to equity
47.485
Interest coverage (TTM)
-8.61%
Profitability
EBITDA (TTM)
-42.27
Gross margin (TTM)
37.52%
Net profit margin (TTM)
-38.81%
Operating margin (TTM)
-22.98%
Effective tax rate (TTM)
-21.86%
Revenue per employee (TTM)
$260,000
Management effectiveness
Return on assets (TTM)
-5.10%
Return on equity (TTM)
-28.32%
Valuation
Price to revenue (TTM)
3.206
Price to book
2.81
Price to tangible book (TTM)
3.15
Growth
Revenue change (TTM)
-15.72%
Earnings per share change (TTM)
194.31%
3-year revenue growth (CAGR)
-34.65%
3-year earnings per share growth (CAGR)
69.83%
Bulls say / Bears say
Amazfit-branded revenue grew 10.2% year-over-year to US$39 million in Q1 2025, marking the first annual increase since Q1 2022 (PR Newswire)
Gross margin expanded to 37.3% in Q1 2025, up from 36.8% a year earlier, driven by higher-margin new product launches and mix improvements (PR Newswire)
Dual-sourcing supply chain strategy—establishing production in both China and Vietnam—mitigated recent tariff headwinds and enhanced operational flexibility (PR Newswire)
Reported a net loss of US$19.7 million in Q1 2025, widening from a US$14.8 million loss in Q1 2024, underscoring ongoing profitability challenges (PR Newswire)
Full-year 2024 revenue plunged 48.3% year-over-year to US$182.6 million, driven by an 88% collapse in Xiaomi-branded wearable sales, highlighting customer concentration risk (PR Newswire)
Lingering supply constraints—particularly delays of the Active 2 Premium and Bip 6 components—hampered product availability and limited potential Q1 2025 sales momentum (PR Newswire)
Data summarised monthly by Lightyear AI. Last updated on 25 Jul 2025.
Zepp Health News
AllArticlesVideos

Amazfit Partners With Female Elite Trail Runners Ruth Croft and Rosa Lara Feliu to Drive Innovation in Sports Watches
Business Wire·1 week ago

NFL Running Back Derrick Henry Joins Amazfit as Athlete Ambassador
Business Wire·1 month ago

Amazfit Expands Active 2 Lineup with the New Active 2 Square — All the Same Features, Now in a Sleek Square Design
Business Wire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Zepp Health stock?
Zepp Health (ZEPP) has a market cap of $575M as of August 22, 2025.
What is the P/E ratio for Zepp Health stock?
The price to earnings (P/E) ratio for Zepp Health (ZEPP) stock is 0 as of August 22, 2025.
Does Zepp Health stock pay dividends?
No, Zepp Health (ZEPP) stock does not pay dividends to its shareholders as of August 22, 2025.
When is the next Zepp Health dividend payment date?
Zepp Health (ZEPP) stock does not pay dividends to its shareholders.
What is the beta indicator for Zepp Health?
Zepp Health (ZEPP) has a beta rating of 1.12. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.